Due to pending litigation with TriPharma, Associates must not refer to any patents when discussing Max WLX™. While we fully believe the lawsuit is without any merit, we are taking every step to ensure Max is proceeding appropriately under the circumstances.
Posted by 
Previous post: Register for the Dallas Showcase
Next post: MaxGXL e-book webinar recording
Comments on this entry are closed.